Xr Securities LLC Pfizer Inc Call Options Transaction History

Xr Securities LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $409,150 - $534,100	9,800 New	9,800 $0
Q3 2022 Oct 18, 2022	SELL	$43.76 - $53.42 $962,720 - $1.18 Million	-22,000 Reduced 63.22%	12,800 $12,000
Q2 2022 Jul 14, 2022	BUY	$46.53 - $55.17 $730,521 - $866,169	15,700 Added 82.2%	34,800 $107,000
Q1 2022 Apr 14, 2022	SELL	$45.75 - $56.69 $1.61 Million - $1.99 Million	-35,100 Reduced 64.76%	19,100 $77,000
Q4 2021 Jan 10, 2022	BUY	$41.32 - $61.25 $1.81 Million - $2.69 Million	43,900 Added 426.21%	54,200 $551,000
Q3 2021 Oct 14, 2021	SELL	$39.25 - $50.42 $416,050 - $534,452	-10,600 Reduced 50.72%	10,300 $19,000
Q2 2021 Jul 26, 2021	SELL	$35.91 - $40.68 $348,326 - $394,596	-9,700 Reduced 31.7%	20,900 $17,000
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $1.95 Million - $2.2 Million	-58,200 Reduced 65.54%	30,600 $12,000
Q4 2020 Jan 13, 2021	BUY	$33.47 - $42.56 $2.4 Million - $3.05 Million	71,600 Added 416.28%	88,800 $100,000
Q3 2020 Oct 28, 2020	BUY	$31.75 - $37.25 $146,050 - $171,350	4,600 Added 36.51%	17,200 $25,000
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $379,512 - $460,404	12,600 New	12,600 $10,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.